Bioorganic and Medicinal Chemistry Letters p. 2859 - 2864 (1998)
Update date:2022-08-03
Topics:
Avenell, Kim Y.
Boyfield, Izzy
Coldwell, Martyn C.
Hadley, Michael S.
Healy, Maureen A. M.
Jeffrey, Philip M.
Johnson, Christopher N.
Nash, David J.
Riley, Graham J.
Scott, Emma E.
Smith, Stephen A.
Stacey, Rachel
Stemp, Geoffrey
Thewlis, Kevin M.
Starting from a series of 2-aminotetralins 1, a novel series of N-[4- (4-phenylbenzoylamino)butyl]-octahydrobenzoquinolines and hexahydrobenzoindoles with high potency and selectivity for the dopamine D3 receptor has been designed. The effect of ligand chirality on binding affinity has been established. Selected derivatives (e.g. 2o, 2p) show high functional selectivity and enhanced in vivo properties compared to 1.
View MoreShantou Baokang Pharmaceutical Co., Ltd.
Contact:+86-754-88873487
Address:5/F B Block Huangshan Bldg Huangshan Rd Shantou
China Synchem Technology Co.,Ltd
website:http://www.cnsynchem.com
Contact:+86-0552-4929311
Address:No.217 Daqing Road
HANGZHOU PANYU CHEMICAL CO.,LIMITED
Contact:+86-571-86578491
Address:Rm 605, NO.1870 Binsheng Road,Binjiang Dist, Hangzhou, China
Xinchang Yueding Chemical Co., Ltd.
Contact:86-571-56926323
Address:NO.90 BEIMENCHENGWAI CHENGGUAN TOWN XINCHANG
Lonzeal Pharmaceuticals Co., Ltd.
website:http://www.lonzeal.com
Contact:+86-13381011962
Address:RM 801, Yue MOMA, No. 26 Anningzhuang Rd. Haidian District, Beijing, China
Doi:10.1021/je60039a037
(1968)Doi:10.1007/BF02321392
(1997)Doi:10.1002/anie.201607918
(2016)Doi:10.1016/S0040-4039(97)10438-5
(1997)Doi:10.1016/S0022-328X(97)00524-X
(1997)Doi:10.1021/jo00837a714
(1970)
